参考文献/References:
[1] 袁蕙芸,蒋宇飞,谭玉婷,等.全球癌症发病与死亡流行现状和变化趋势[J].肿瘤防治研究,2021,48(6):642-646.
[2] 岳 英,董锦华,肖月梅.肺免疫微环境中调节因子表达对肿瘤生长和转移的影响[J].陕西医学杂志,2021,50(4):495-498,502.
[3] 栾英桥,杨佳幸,陶嫦立,等.肠道菌群影响肠道细胞免疫的研究进展[J].中国免疫学杂志,2018,25(34):1734-1737.
[4] 刘 峰,严 晶,卢冬雪,等.肠道微生态研究与中医本质探索[J].中医学报,2019,9(34):1859-1863.
[5] 吴国琳,余国友,卢雯雯,等.肠道微生态的中医本质探讨[J].中华中医药学刊,2015,33(11):2586-2588.
[6] 李玲霞,白 玲,张云清,等.分娩方式对学龄期儿童肺功能的影响[J].陕西医学杂志,2020,49(10):1277-1279.
[7] Thiele OE,Fan H,Tam AJ,et al.The myeloid immune signature of enterotoxigenic bacteroides fragilis-induced murine colon tumorigenesis[J].Mucosal Immunol,2017,10(2):421-433.
[8] Chen J,Pitmon E,Wang K.Microbiome,inflammation and colorectal cancer[J].Semin Immunol,2017,32:43-53.
[9] Cheng WY,Wu CY,Yu J.The role of gut microbiota in cancer treatment:Friend or foe?[J].Gut,2020,69(10):1867-1876.
[10] 张雪莹,秦环龙.肿瘤免疫治疗与肠道菌群关系的研究进展[J].上海预防医学,2019,31(10):817-823.
[11] Sivan A,Corrales L,Hubert N,et al.Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy[J].Science,2015,350(6264):1084-1089.
[12] Katayama Y,Yamada T,Shimamoto T,et al.The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in japanese responder patients with advanced non-small cell lung cancer[J].Transl Lung Cancer Res,2019,8(6):847-853.
[13] Zheng Y,Wang T,Tu X,et al.Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma[J].J Immunother Cancer,2019,7(1):193.
[14] Gopalakrishnan V,Spencer CN,Nezi L,et al.Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J].Science,2018,359(6371):97-103.
[15] 张晓博,杨宪武,党惠娇,等.IL-8和TNF-α在美沙拉嗪和美常安胶囊在治疗溃疡性结肠炎患者血清中表达变化[J].河北医药,2010,32(5):589-590.
[16] Xia C,Jiang C,Li W,et al.A phase Ⅱ randomized clinical trial and mechanistic studies using improved probiotics to prevent oral mucositis induced by concurrent radiotherapy and chemotherapy in nasopharyngeal carcinoma[J].Front Immunol,2021,12:618150.
[17] 张阿润,刘传波,赵鹏飞,等.肠道菌群与肺癌关系的研究进展[J].癌症进展,2021,19(19):1950-1953.
[18] 李丽秋,张德慧,马淑霞,等.中草药白花蛇舌草对实验性大肠癌作用机制的研究[J].中国微生态学杂志,2008,20(3):224-225.
[19] 丁佳敏,张 竞,肖明明,等.方剂“从肠道菌群论治”的理论与实践[J].世界科学技术-中医药现代化,2018,20(2):157-161.
[20] 丁维俊,高 峰,杨 杰.肾阳虚证患者肠道菌群失调状况的临床研究[J].新中医,2007,39(1):9-11.
[21] 张 玉,张军峰,杨亚平.近十五年来肠道微生态的中医药研究概况[J].辽宁中医杂志,2016,43(11):2442-2445.
[22] 董开忠,高永盛,秦宁恩加,等.参苓白术散对抗生素引起肠道菌群失调小鼠的影响[J].中国实验方剂学杂志,2015,21(1):154-157.
[23] 袁文婷,肖茂良,肖 锋.半枝莲提取物通过PI3K-Akt信号通路抑制胰腺癌模型大鼠肿瘤生长的机制研究[J].陕西中医,2021,42(12):1676-1679.
[24] 敬秀平,宋小平,刘 珊.加味白头翁汤灌肠治疗慢性溃疡性结肠炎临床研究[J].陕西中医,2021,42(8):1060-1063.
相似文献/References:
[1]黄 飞,闫小光△,刘铜华.糖肾汤对代谢综合征患者肠道菌群影响的研究*[J].陕西中医,2019,(12):1713.
[2]张璐,韩俊泉,王红.名中医王红治疗代谢相关脂肪性肝病临床经验[J].陕西中医,2025,46(6):813.[doi:DOI:10.3969/j.issn.1000-7369.2025.06.019]
ZHANG Lu,HAN Junquan,WANG Hong.WANG Hong’s clinical experience in treating metabolic associated fatty liver disease[J].,2025,46(6):813.[doi:DOI:10.3969/j.issn.1000-7369.2025.06.019]
[3]杜玉双,罗磊,韩博闻,等.基于“肠道-微生物群-肝脏”轴探讨中药调节肠道菌群治疗非酒精性脂肪性肝病研究进展[J].陕西中医,2025,46(6):857.[doi:DOI:10.3969/j.issn.1000-7369.2025.06.029]
DU Yushuang,LUO Lei,HAN Bowen,et al.Research progress on the regulation of gut microbiota by traditional Chinese medicine to treat non-alcoholic fatty liver disease based on the “gut-microbiota-liver” axis[J].,2025,46(6):857.[doi:DOI:10.3969/j.issn.1000-7369.2025.06.029]
[4]张洪艳,刘风静,孟胜喜,等.清化活血方对高尿酸血症患者血清炎症因子及肠道菌群的影响临床研究[J].陕西中医,2025,46(10):1330.[doi:DOI:10.3969/j.issn.1000-7369.2025.10.006]
ZHANG Hongyan,LIU Fengjing,MENG Shengxi,et al.Effect of Qinghua Huoxue formula on serum inflammatory factors and intestinal microbiota in patients with hyperuricemia[J].,2025,46(6):1330.[doi:DOI:10.3969/j.issn.1000-7369.2025.10.006]
[5]文圆,范艺缤,许莹,等.调脏舒痢方直肠滴入联合美沙拉嗪肠溶片治疗溃疡性结肠炎临床研究[J].陕西中医,2025,46(10):1351.[doi:DOI:10.3969/j.issn.1000-7369.2025.10.010]
WEN Yuan,FAN Yibin,XU Ying,et al.Tiaozang Shuli prescription rectal instillation combined with mesalazine enteric-coated tablets in the treatment of ulcerative colitis[J].,2025,46(6):1351.[doi:DOI:10.3969/j.issn.1000-7369.2025.10.010]
[6]钟磊,范娜,马龙,等.寒喘祖帕对过敏性哮喘小鼠的抗炎效果及其对肠道菌群结构调节作用研究[J].陕西中医,2026,(1):21.[doi:DOI:10.3969/j.issn.1000-7369.2026.01.004]
ZHONG Lei,FAN Na,MA Long,et al.Study on the anti-inflammatory effects and intestinal microbiota structure regulation of Hanchuan zupa in mice with allergic asthma[J].,2026,(6):21.[doi:DOI:10.3969/j.issn.1000-7369.2026.01.004]
[7]许静,惠振亮,张晓乐,等.探讨“脑-肠轴”理论下中医药治疗卒中后抑郁研究进展[J].陕西中医,2026,(1):133.[doi:DOI:10.3969/j.issn.1000-7369.2026.01.024]
XU Jing,HUI Zhenliang,ZHANG Xiaole,et al.Research progress on the treatment of post-stroke depression based on the “Brain-Gut Axis” in traditional Chinese medicine[J].,2026,(6):133.[doi:DOI:10.3969/j.issn.1000-7369.2026.01.024]
[8]焦守凤,王文娟,南燕燕.桂枝茯苓丸辅助治疗湿热瘀阻型输卵管性不孕症临床研究[J].陕西中医,2026,(3):329.[doi:DOI:10.3969/j.issn.1000-7369.2026.03.007]
JIAO Shoufeng,WANG Wenjuan,NAN Yanyan.Clinical study of Guizhi Fuling pills in the adjuvant treatment of damp-heat stasis obstructive tubal infertility[J].,2026,(6):329.[doi:DOI:10.3969/j.issn.1000-7369.2026.03.007]
[9]贺屹巍,刘毅,李玮,等.八珍汤加减对腹腔镜胃癌根治术后患者肠道菌群、胃肠激素及免疫功能的影响[J].陕西中医,2026,(4):502.[doi:DOI:10.3969/j.issn.1000-7369.2026.04.013]
HE Yiwei,LIU Yi,LI Wei,et al.Effects of modified Bazhen decoction on intestinal flora,gastrointestinal hormones and immune function in patients after laparoscopic radical gastrectomy for gastric cancer[J].,2026,(6):502.[doi:DOI:10.3969/j.issn.1000-7369.2026.04.013]
[10]李维琦,刘亚军.基于FXR信号通路探讨中医药干预溃疡性结肠炎研究进展[J].陕西中医,2026,(4):568.[doi:DOI:10.3969/j.issn.1000-7369.2026.04.027]
LI Weiqi,LIU Yajun.Research progress on traditional Chinese medicine intervention in ulcerative colitis based on the FXR signaling pathway[J].,2026,(6):568.[doi:DOI:10.3969/j.issn.1000-7369.2026.04.027]